Amgen collects, uses and discloses various types of personal information about patients, healthcare providers, clinical trial participants, customers, Amgen staff members or their representatives, and others for a variety of lawful business purposes. The lawful collection and use of such information is important to Amgen’s business activities. U.S. federal and state laws and the laws of other countries require companies to implement certain safeguards to ensure the protection of personal information, i.e., regulate the collection, use, and disclosure of personal information. Amgen is committed to the lawful stewardship of personal information that is collected, stored and used by Amgen.

It is Amgen’s policy to comply with all applicable laws and regulations that protect Personal Information. (“Personal Information” generally means information relating to an individual whose identity is apparent, or can be ascertained from the information by direct or indirect means.)

Amgen functions and business units that are engaged in the collection, handling and use of Personal Information are responsible for:

• Collecting, processing, using and transferring Personal Information in accordance with laws and regulations applicable in the relevant jurisdictions;
   
• Complying with specific protocols or agreements Amgen may undertake with respect to the handling of Personal Information (e.g., commitments made in clinical trial patient informed consent forms or in an Amgen Web site’s privacy notice);
   
• Implementing appropriate security measures to protect Personal Information against unauthorized or improper access, destruction, alteration, storage or use; and
   
• Taking the necessary steps to respond to any incident involving a potential breach in the security of Personal Information. 

To view PDF Files, you must have Acrobat Reader.